First Header Logo Second Header Logo

Timothy Pardee

Concepts (244)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute
24
2020
200
6.880
Why?
Antineoplastic Agents
15
2020
611
3.210
Why?
Antineoplastic Combined Chemotherapy Protocols
11
2020
462
2.780
Why?
Salvage Therapy
4
2019
134
1.420
Why?
Drug Resistance, Neoplasm
7
2019
105
1.350
Why?
Hematopoietic Stem Cell Transplantation
2
2020
95
1.170
Why?
Cytarabine
7
2020
55
1.160
Why?
Apoptosis
8
2019
368
1.090
Why?
Fluorodeoxyuridylate
3
2016
23
1.060
Why?
Neoplasms
3
2018
695
1.050
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2017
44
1.050
Why?
Sulfides
6
2019
27
1.040
Why?
Caprylates
6
2019
28
1.040
Why?
Enzyme Inhibitors
3
2020
176
1.020
Why?
Tumor Suppressor Protein p53
4
2014
79
0.930
Why?
Bone Marrow
3
2020
71
0.890
Why?
Mitochondria
4
2019
188
0.840
Why?
Cell Membrane
1
2020
103
0.690
Why?
Aged
22
2020
10398
0.660
Why?
Humans
36
2020
32297
0.650
Why?
Mice, Inbred C57BL
7
2017
773
0.640
Why?
Middle Aged
21
2020
11949
0.630
Why?
Body Composition
1
2020
384
0.620
Why?
Resuscitation Orders
1
2017
12
0.610
Why?
Glycerophosphates
1
2017
4
0.600
Why?
Myelodysplastic Syndromes
2
2014
24
0.590
Why?
Neoplasm Recurrence, Local
2
2019
370
0.590
Why?
Deoxycytidine
1
2017
68
0.580
Why?
Intensive Care Units
1
2017
118
0.570
Why?
Neoplasm Proteins
2
2014
149
0.570
Why?
fms-Like Tyrosine Kinase 3
2
2019
18
0.560
Why?
Leukemia
2
2014
40
0.560
Why?
Nucleosides
1
2016
10
0.540
Why?
Female
23
2020
20126
0.530
Why?
Survival Rate
7
2020
894
0.520
Why?
DNA Topoisomerases, Type I
2
2012
9
0.520
Why?
Thymidylate Synthase
2
2012
14
0.520
Why?
Cytogenetics
1
2015
7
0.510
Why?
Animals
12
2018
7694
0.510
Why?
Mice
9
2018
2524
0.510
Why?
Fas Ligand Protein
1
2014
8
0.500
Why?
Male
22
2020
19488
0.500
Why?
Hydroxamic Acids
1
2014
21
0.500
Why?
Membrane Microdomains
1
2014
24
0.500
Why?
Prognosis
9
2020
1523
0.490
Why?
Lipids
1
2016
226
0.480
Why?
Hematologic Neoplasms
1
2014
34
0.480
Why?
Pyrimidines
1
2014
65
0.480
Why?
DNA Damage
4
2017
100
0.460
Why?
Azacitidine
1
2013
28
0.460
Why?
Mitoxantrone
3
2019
19
0.460
Why?
Remission Induction
5
2020
84
0.460
Why?
Aged, 80 and over
9
2020
4050
0.440
Why?
Adult
13
2020
9467
0.430
Why?
Oncogene Proteins
1
2012
6
0.430
Why?
Gene Expression Regulation, Leukemic
1
2012
24
0.430
Why?
Apoptosis Regulatory Proteins
1
2012
43
0.420
Why?
DNA Methylation
1
2013
142
0.420
Why?
Treatment Outcome
8
2020
3358
0.420
Why?
Tumor Suppressor Proteins
1
2012
72
0.410
Why?
Proto-Oncogene Proteins
1
2012
94
0.410
Why?
Disease Models, Animal
5
2014
1040
0.390
Why?
Tandem Repeat Sequences
1
2011
6
0.390
Why?
Leukemia, Myeloid
1
2011
24
0.380
Why?
Membrane Proteins
1
2012
260
0.380
Why?
Cell Line, Tumor
5
2017
736
0.370
Why?
Aniline Compounds
2
2020
27
0.360
Why?
Geriatric Assessment
4
2020
395
0.360
Why?
Prospective Studies
7
2020
2274
0.350
Why?
Doxorubicin
3
2017
79
0.340
Why?
Recurrence
3
2019
266
0.310
Why?
Mutation
2
2020
503
0.300
Why?
Follow-Up Studies
4
2020
2296
0.290
Why?
Survival Analysis
4
2020
491
0.280
Why?
Pancreatic Neoplasms
2
2019
142
0.280
Why?
Retrospective Studies
6
2018
3514
0.280
Why?
Adenocarcinoma
2
2019
315
0.260
Why?
Neoplasm Transplantation
2
2017
75
0.250
Why?
Neoplasm Staging
2
2018
459
0.250
Why?
Age Factors
4
2018
1204
0.240
Why?
Drug Administration Schedule
2
2015
279
0.240
Why?
Mice, Transgenic
2
2017
261
0.230
Why?
Transcriptional Elongation Factors
1
2003
1
0.230
Why?
RNA Polymerase II
1
2003
2
0.220
Why?
Genes, Regulator
1
2003
5
0.220
Why?
Guanosine Triphosphate
1
2003
8
0.220
Why?
International Agencies
2
2019
9
0.220
Why?
Comorbidity
5
2018
572
0.210
Why?
Transcription, Genetic
1
2003
143
0.210
Why?
Electron Transport
2
2019
16
0.200
Why?
Hyperglycemia
2
2018
84
0.190
Why?
RNA, Messenger
1
2003
534
0.190
Why?
Isocitrate Dehydrogenase
1
2020
7
0.190
Why?
Benzimidazoles
1
2020
34
0.180
Why?
Pyrazines
1
2019
14
0.180
Why?
Young Adult
2
2018
2626
0.170
Why?
Proto-Oncogene Proteins c-bcl-2
1
2019
40
0.170
Why?
Heme
1
2019
61
0.160
Why?
Cell Proliferation
2
2018
602
0.160
Why?
HSP90 Heat-Shock Proteins
1
2018
10
0.160
Why?
Citric Acid Cycle
1
2018
11
0.160
Why?
Combined Modality Therapy
1
2020
567
0.160
Why?
Cell Respiration
1
2018
22
0.160
Why?
Protein Biosynthesis
1
2018
45
0.160
Why?
Retreatment
1
2018
42
0.150
Why?
HL-60 Cells
2
2014
14
0.150
Why?
Proportional Hazards Models
3
2015
759
0.150
Why?
Philadelphia Chromosome
1
2017
4
0.150
Why?
Protein Kinase C
1
2017
32
0.150
Why?
Tumor Burden
1
2017
61
0.150
Why?
Hematologic Diseases
1
2017
24
0.150
Why?
Drug Screening Assays, Antitumor
1
2017
58
0.150
Why?
Oxygen Consumption
1
2018
150
0.150
Why?
Patient Transfer
1
2017
44
0.150
Why?
Splenomegaly
1
2016
7
0.140
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
2016
10
0.140
Why?
Cosmic Radiation
1
2016
14
0.140
Why?
Cell Line
1
2018
462
0.140
Why?
Biopsy
1
2018
273
0.140
Why?
Random Allocation
1
2017
220
0.140
Why?
Small Cell Lung Carcinoma
1
2016
17
0.140
Why?
DNA, Neoplasm
2
2013
56
0.140
Why?
Radiation Injuries
1
2016
72
0.140
Why?
Biological Availability
1
2016
22
0.140
Why?
Tumor Cells, Cultured
2
2016
171
0.140
Why?
Blood Glucose
1
2018
496
0.130
Why?
Asparaginase
1
2015
5
0.130
Why?
Depression
2
2016
436
0.130
Why?
Dose-Response Relationship, Drug
1
2017
675
0.130
Why?
Activities of Daily Living
1
2016
258
0.130
Why?
Transplantation, Homologous
1
2015
151
0.130
Why?
Tumor Stem Cell Assay
1
2014
12
0.130
Why?
Ribonucleotide Reductases
1
2014
6
0.130
Why?
Cognition
2
2016
551
0.120
Why?
Drug Evaluation, Preclinical
1
2014
65
0.120
Why?
Lung
1
2016
262
0.120
Why?
Polypharmacy
1
2014
20
0.120
Why?
Oligonucleotides
1
2014
30
0.120
Why?
Hematopoietic Stem Cells
1
2014
100
0.120
Why?
Myeloid-Lymphoid Leukemia Protein
2
2011
8
0.120
Why?
Mice, Inbred BALB C
1
2014
171
0.120
Why?
Drug Evaluation
1
2013
15
0.120
Why?
Stem Cells
1
2016
310
0.120
Why?
Occupational Exposure
1
2016
238
0.120
Why?
Databases, Factual
1
2015
355
0.110
Why?
Hospitalization
2
2018
465
0.110
Why?
Positron-Emission Tomography
1
2014
190
0.110
Why?
Gene Fusion
1
2012
2
0.110
Why?
Nuclear Pore Complex Proteins
1
2012
6
0.110
Why?
Translocation, Genetic
1
2012
21
0.110
Why?
Phenotype
1
2015
656
0.110
Why?
Proto-Oncogene Proteins c-mdm2
1
2012
8
0.110
Why?
DNA Replication
1
2012
34
0.110
Why?
Homeodomain Proteins
1
2012
51
0.110
Why?
Antimetabolites, Antineoplastic
1
2012
49
0.110
Why?
Lung Neoplasms
1
2016
409
0.110
Why?
Clinical Trials as Topic
1
2014
316
0.110
Why?
Trans-Activators
1
2012
46
0.100
Why?
Histones
1
2012
54
0.100
Why?
Inhibitory Concentration 50
1
2012
23
0.100
Why?
Substrate Specificity
1
2012
90
0.100
Why?
Xenograft Model Antitumor Assays
1
2012
119
0.100
Why?
Transcription Factors
1
2012
181
0.100
Why?
Benzenesulfonates
1
2011
3
0.100
Why?
Gene Duplication
1
2011
5
0.100
Why?
Phenylurea Compounds
1
2011
10
0.100
Why?
Niacinamide
1
2011
8
0.100
Why?
Genetic Predisposition to Disease
1
2015
849
0.100
Why?
Signal Transduction
1
2014
701
0.090
Why?
RNA Interference
1
2011
77
0.090
Why?
Pyridines
1
2011
81
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
264
0.090
Why?
Acute Disease
1
2011
255
0.090
Why?
Blotting, Western
1
2011
305
0.090
Why?
Risk Factors
2
2015
3876
0.090
Why?
Tomography, X-Ray Computed
1
2014
920
0.080
Why?
Time Factors
1
2015
2181
0.080
Why?
Leucovorin
2
2019
25
0.080
Why?
Fluorouracil
2
2019
82
0.080
Why?
Cardiovascular Diseases
1
2015
1133
0.070
Why?
Diabetes Mellitus, Type 2
1
2015
1428
0.070
Why?
Macromolecular Substances
1
2003
18
0.060
Why?
Molecular Weight
1
2003
43
0.060
Why?
Saccharomyces cerevisiae
1
2003
20
0.060
Why?
Binding Sites
1
2003
132
0.050
Why?
DNA Breaks, Double-Stranded
2
2012
17
0.050
Why?
DNA-Binding Proteins
1
2003
149
0.050
Why?
DNA
1
2003
229
0.050
Why?
DNA Mutational Analysis
1
2020
72
0.050
Why?
Daunorubicin
1
2020
27
0.050
Why?
Disease-Free Survival
1
2020
320
0.040
Why?
Electron Transport Chain Complex Proteins
1
2019
8
0.040
Why?
Gene Knockout Techniques
1
2019
12
0.040
Why?
Membrane Potential, Mitochondrial
1
2019
17
0.040
Why?
Administration, Oral
1
2019
185
0.040
Why?
Mitochondrial Membranes
1
2019
21
0.040
Why?
Transduction, Genetic
1
2019
42
0.040
Why?
Sulfonamides
1
2019
67
0.040
Why?
Lymphopenia
1
2017
12
0.040
Why?
Hypokalemia
1
2017
14
0.040
Why?
Neutropenia
1
2017
30
0.040
Why?
Hypoalbuminemia
1
2017
12
0.040
Why?
Sensation Disorders
1
2017
20
0.040
Why?
Thrombocytopenia
1
2017
32
0.040
Why?
Maximum Tolerated Dose
1
2017
60
0.040
Why?
Camptothecin
1
2017
53
0.040
Why?
Organoplatinum Compounds
1
2017
47
0.040
Why?
Body Burden
1
2016
7
0.040
Why?
Abdominal Pain
1
2017
45
0.040
Why?
Astronauts
1
2016
8
0.040
Why?
Anemia
1
2017
60
0.040
Why?
Topotecan
1
2016
17
0.040
Why?
Radiation Dosage
1
2016
81
0.030
Why?
Liver
1
2019
486
0.030
Why?
Genome, Human
1
2016
133
0.030
Why?
Physical Examination
1
2016
94
0.030
Why?
Sepsis
1
2017
156
0.030
Why?
Mental Health
1
2016
113
0.030
Why?
Patient Discharge
1
2016
183
0.030
Why?
Diabetes Mellitus
1
2018
410
0.030
Why?
Survivors
1
2016
157
0.030
Why?
Mobility Limitation
1
2016
221
0.030
Why?
Logistic Models
1
2015
788
0.030
Why?
Affective Symptoms
1
2013
16
0.030
Why?
Leukemia, Monocytic, Acute
1
2012
2
0.030
Why?
Thymine
1
2012
6
0.030
Why?
S Phase
1
2012
15
0.030
Why?
Alkaloids
1
2012
9
0.030
Why?
Secondary Prevention
1
2013
65
0.030
Why?
Leukemia, Promyelocytic, Acute
1
2012
21
0.030
Why?
Nursing Assessment
1
2011
11
0.030
Why?
Multivariate Analysis
1
2013
696
0.020
Why?
Feasibility Studies
1
2011
294
0.020
Why?
Motor Activity
1
2013
327
0.020
Why?
Predictive Value of Tests
1
2013
877
0.020
Why?
Disability Evaluation
1
2011
236
0.020
Why?
Core Binding Factor Alpha 2 Subunit
1
2009
8
0.020
Why?
Genes, ras
1
2009
25
0.020
Why?
Oncogene Proteins, Fusion
1
2009
16
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2009
262
0.020
Why?
Gene Expression Profiling
1
2009
326
0.020
Why?
Genotype
1
2009
742
0.020
Why?
Cohort Studies
1
2011
1832
0.020
Why?
North Carolina
1
2011
1520
0.020
Why?
Pardee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (244)
Explore
_
Co-Authors (32)
Explore
_
Similar People (49)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_